Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19
Status:
Completed
Trial end date:
2020-08-20
Target enrollment:
Participant gender:
Summary
This is open-labe randomized multicenter comparative Phase III study conducted in 5 medical
facilities. The objective of the study is to assess the efficacy and safety of Favipiravir
compared with the Standard of care (SOC) in hospitalized patients with moderate COVID-19
pneumonia.